Georges Gaudriault
Chief Tech/Sci/R&D Officer chez DEINOVE
Profil
Georges Gaudriault is currently the Chief Scientific Officer at Deinove SA. Previously, he held positions as the Scientific Director at Obe Therapy Biotechnology SAS, Obetherapy, and MedinCell SA. Dr. Gaudriault obtained his undergraduate, graduate, and doctorate degrees from the University of Nice Sophia Antipolis.
Postes actifs de Georges Gaudriault
| Sociétés | Poste | Début |
|---|---|---|
| DEINOVE | Chief Tech/Sci/R&D Officer | 23/05/2017 |
Anciens postes connus de Georges Gaudriault
| Sociétés | Poste | Fin |
|---|---|---|
Obe Therapy Biotechnology SAS
 Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Chief Tech/Sci/R&D Officer | - |
Obetherapy
 Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Chief Tech/Sci/R&D Officer | - |
| MEDINCELL S.A. | Chief Tech/Sci/R&D Officer | - |
Formation de Georges Gaudriault
| University of Nice Sophia Antipolis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDINCELL S.A. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Deinove SA
 Deinove SA BiotechnologyHealth Technology Deinove SA is a biotechnology company, which engages in the development of new-generation anti-infective antibiotics and bioactives. Its portfolio include Phy-N-Resist and HEBELYS. The company was founded by Philippe Pouletty and Miroslav Radman on October 11, 2006 and is headquartered in Grabels, France. | Health Technology |
Obe Therapy Biotechnology SAS
Obe Therapy Biotechnology SAS Medical/Nursing ServicesHealth Services Obe Therapy Biotechnology SAS Discovers and develops therapeutics and novel drugs for obesity. The firm focuses on the genetics of lean and hypolipidemic phenotype. The company was founded by Itzik Harosh in January 2000 and is headquartered in Evry, France. | Health Services |
Obetherapy
Obetherapy Pharmaceuticals: MajorHealth Technology Obetherapy is a French biotech company that focuses on developing new drugs for obesity and hypercholesterolemia. | Health Technology |
